Equipment, Utilities & Facility Qualification (IQ/OQ/PQ)
Digital Systems for Tracking Requalification, Periodic Review and Change Control Introduction to Regulatory Expectations in Validation Validation is an essential component of compliant operations within the pharmaceutical industry. Regulatory bodies such as the US FDA, EMA, and MHRA mandate that organizations engage in systematic validation processes to ensure product quality, safety, and efficacy. According to the US FDA Guidance on…
Global Harmonisation of Periodic Review and Requalification SOPs Global Harmonisation of Periodic Review and Requalification SOPs Introduction to Periodic Review and Requalification in Pharmaceutical Validation In the pharmaceutical industry, compliance with regulatory expectations is essential for maintaining the integrity and quality of products. Periodic review and requalification are crucial components of the validation process, ensuring that qualified equipment remains fit…
Risk Based Requalification Protocols When Equipment or Utility Changes Occur Risk Based Requalification Protocols When Equipment or Utility Changes Occur In the pharmaceutical industry, ensuring the quality and safety of products is paramount. One critical aspect of maintaining quality is the validation of equipment and utilities used in manufacturing. Regulatory expectations for validation have evolved, and there is now a…
Regulatory Expectations for Lifecycle Management of Qualified Equipment In the pharmaceutical industry, ensuring the integrity and compliance of qualified equipment is critical to maintaining product quality and patient safety. Regulatory agencies such as the FDA, EMA, MHRA, and guidelines set forth in EU GMP Annex 15 provide a framework for lifecycle management of equipment. This step-by-step tutorial guide aims to…
Integrating Deviation, CAPA and Maintenance Data into Periodic Reviews Integrating Deviation, CAPA and Maintenance Data into Periodic Reviews The pharmaceutical industry operates under stringent regulatory frameworks, necessitating comprehensive validation practices to ensure product quality and patient safety. This article aims to elucidate the integration of deviations, Corrective and Preventive Actions (CAPAs), and maintenance data into the periodic review of qualified…
CMO Oversight for Requalification and Periodic Review of Contract Equipment CMO Oversight for Requalification and Periodic Review of Contract Equipment In the pharmaceutical industry, compliance with regulatory expectations is paramount, especially when it comes to maintaining the quality and efficacy of products. Contract manufacturers (CMOs) play a critical role in this process, where oversight becomes essential to ensure that qualified…
Capital Projects, Upgrades and Their Impact on Existing IQ OQ PQ Status The pharmaceutical industry continually faces challenges from evolving technologies and regulatory landscapes. With the constant push for innovation and efficiency, capital projects such as retrofits and expansions are integral to maintaining compliance and enhancing operational capacity. However, these upgrades necessitate careful consideration of their impact on existing equipment…
Change Control Impact Assessments Focused on Validation and Qualification Status Introduction to Change Control and Validation Status Change control is a critical process in the pharmaceutical industry, primarily regulated under Good Manufacturing Practice (GMP) guidelines established by organizations such as the FDA, EMA, and MHRA. The goal of change control is to systematically evaluate and manage changes to processes, equipment,…
KPI Dashboards for Lifecycle Management of Qualified Equipment and Utilities KPI Dashboards for Lifecycle Management of Qualified Equipment and Utilities Understanding Lifecycle Management in Pharmaceutical Validation Lifecycle management is an essential element in ensuring compliance with regulatory expectations for pharmaceutical validation. The US FDA, EMA, and other regulatory bodies articulate the need for rigorous validation processes that encompass the entire…
Case Studies of Poor Lifecycle Management and Enforcement Actions Case Studies of Poor Lifecycle Management and Enforcement Actions Effective lifecycle management of pharmaceutical equipment and utilities is paramount to ensure compliance with good manufacturing practices (cGMP) and regulatory standards. However, instances of poor lifecycle management can lead to severe consequences for pharmaceutical companies, including regulatory actions from authorities such as…